LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.30 | 21.74 | 8976 | 6244 | 1.4374 | 1.0909 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.30 | 21.74 | 5777 | 6244 | 0.9251 | 0.9810 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.30 | 21.74 | 9471 | 6244 | 1.5167 | 1.1047 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.27 | 21.74 | 682 | 6201 | 0.1100 | 0.5258 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.27 | 21.74 | 9352 | 6201 | 1.5079 | 1.1033 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.27 | 21.74 | 5611 | 6201 | 0.9047 | 0.9756 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.27 | 21.74 | 9737 | 6201 | 1.5700 | 1.1137 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.24 | 21.74 | 553 | 6162 | 0.0897 | 0.4877 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.24 | 21.74 | 9661 | 6162 | 1.5678 | 1.1135 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.24 | 21.74 | 5037 | 6162 | 0.8174 | 0.9511 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.24 | 21.74 | 9902 | 6162 | 1.6069 | 1.1199 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.21 | 21.74 | 325 | 6235 | 0.0521 | 0.3928 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.21 | 21.74 | 10008 | 6235 | 1.6050 | 1.1193 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.21 | 21.74 | 4403 | 6235 | 0.7061 | 0.9165 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.21 | 21.74 | 10047 | 6235 | 1.6112 | 1.1203 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.18 | 21.74 | 342 | 6114 | 0.0559 | 0.4031 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.18 | 21.74 | 10235 | 6114 | 1.6739 | 1.1307 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.18 | 21.74 | 3606 | 6114 | 0.5898 | 0.8743 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.18 | 21.74 | 10161 | 6114 | 1.6618 | 1.1288 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.15 | 21.74 | 309 | 6167 | 0.0501 | 0.3851 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.15 | 21.74 | 10534 | 6167 | 1.7079 | 1.1358 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.15 | 21.74 | 3047 | 6167 | 0.4940 | 0.8342 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.15 | 21.74 | 10296 | 6167 | 1.6693 | 1.1298 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.12 | 21.74 | 272 | 6211 | 0.0438 | 0.3630 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.12 | 21.74 | 10743 | 6211 | 1.7295 | 1.1389 | MN20160310_N01 | E09 |